Novel Therapies Boosting T Cell Immunity in Epstein Barr Virus-Associated Nasopharyngeal Carcinoma

Novel Therapies Boosting T Cell Immunity in Epstein Barr Virus-Associated Nasopharyngeal Carcinoma

Nasopharyngeal carcinoma (NPC) is a malignant tumour of the head and neck affecting localised regions of the world, with the highest rates described in Southeast Asia, Northern Africa, and Greenland. Its high morbidity rate is linked to both late-stage diagnosis and unresponsiveness to conventional...

Full description

Bibliographic Details
Main Authors: Sarah Renaud, Anthony Lefebvre, Serge Mordon, Olivier Moralès, Nadira Delhem
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:International Journal of Molecular Sciences
Subjects:
therapy
T cell
immunity
EBV
nasopharyngeal carcinoma
Online Access:https://www.mdpi.com/1422-0067/21/12/4292

Internet

https://www.mdpi.com/1422-0067/21/12/4292

Similar Items